Accepted for Publication: March 30, 2015.
Published Online: May 7, 2015. doi:10.1001/jamadermatol.2015.0502.
Study concept and design: Pomerantz, Swetter, Warshaw, Weinstock.
Acquisition, analysis, or interpretation of data: All authors.
Drafting of the manuscript: Pomerantz, Weinstock.
Critical revision of the manuscript for important intellectual content: All authors.
Statistical analysis: Pomerantz, Lew, Weinstock.
Obtained funding: Weinstock.
Administrative, technical, or material support: Hogan, Eilers, Swetter, Warshaw, Stricklin, Dellavalle, Konnikov, Werth, Keri, Weinstock.
Study supervision: Eilers, Chen, Konnikov, Werth, Keri, Weinstock.
Conflict of Interest Disclosures: Dr Dellavalle receives royalties from UpToDate. Dr Werth serves as a consultant to Sanofi, Idera, Novartis, Biogen, Medimmune, Pfizer, Syntimmune, Roche, Genetech, GSK, UCB, Kirin, Celgen. Dr Werth received grants from Novartis, Biogen, and Celgene. Dr Werth owns stocks of UV Therapeutics. Dr Weinstock is employed by University Dermatology Inc (Brown University Department of Dermatology’s faculty practice) in addition to his listed affiliations. Dr Weinstock served as a consultant to AbbVie, Castle, Celgene, Melafind, Merck, Palatin Technologies, and Personal Care Products Council.
Funding/Support: The study was supported by the Office of Research and Development Cooperative Studies Program, US Department of Veterans Affairs.
Role of the Funder/Sponsor: The Office of Research and Development Cooperative Studies Program participated in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Group Information: Key personnel of the VAKCC trial include the following (superscript numbers refer to clinical centers listed at the end of this section): Study Chairman’s Office, Providence, Rhode Island: Martin A. Weinstock, MD, PhD (chair), Kimberly Marcolivio, MEd (national coordinator). Executive/Planning Committee: Martin A. Weinstock, MD, PhD; Suephy C. Chen, MD, MS4; Robert P. Dellavalle, MD, PhD, MSPH8; Erin M. Warshaw, MD, MS6; John J. DiGiovanna, MD; Ryan Ferguson, ScD, MPH; Robert Lew, PhD Robert Ringer, PharmD; Jean Yoon, PhD; Ciaran S. Phibbs, PhD; Ken Kraemer, MD (only in planning committee). Clinical Centers (Investigators): Daniel Hogan, MD1; David Eilers, MD2; Susan Swetter, MD3; Suephy C. Chen, MD, MD4; Sharon Jacob, MD5; Erin M. Warshaw, MD, MS6; George Stricklin, MD, PhD7; Robert P. Dellavalle, MD, PhD, MSPH8; Nellie Konnikov, MD9; Victoria P. Werth, MD10; Navjeet Sidhu-Malik, MD11; Jonette Keri, MD, PhD12. Clinical Centers (Co-investigators): James W. Swan, MD2; Kristin Nord, MD3; Brian Pollack, MD, PhD4; Stephen Kempiak, MD, PhD5; Whitney High, MD8; Nicole Fett, MD10; Russell P. Hall III, MD11; Javier Alonso-Llamazares, MD, PhD12; Georgette Rodriguez, MD, MS12. Clinical Centers (Study Coordinators): Lorine Sisler1; Mary O’Sullivan, MSN, RN, NP2; Sonya Wilson, RN3; Madhuri Agrawal, RN3; Debra Bartenfeld, RN4; Keith Nicalo, RN5; Deb Johnson, RN6; Patricia Parks6; Barbara Bidek, RN7; Nancy Boyd, RN8; Barbara Watson, RN8; Dianne Wolfe, RN8; Mark Zacheis, RN9; Joyce Okawa, RN10; Mary Ann Iannacchione, MSN11; Jalima Quintero, RN12. Clinical Centers (Unblinded Practitioners): Subbarayudu Cuddapah, MD1; Karen Muller, NP1; Vanessa Lichon, MD3; Todd Anhalt, MD3; Vista Khosravi, MD3; Zakia Rahman, MD3; Leslie Lawley, MD4; Roberta McCoy, NP5; Neal Foman, MD6; Andrea Bershow, MD6; John Zic, MD7; Jami Miller, MD7; H. Alan Arbuckle, MD8; Linnea Hemphill, RN, NP8; Mayumi Fujita, MD8; David Norris, MD8; Preethi Ramaswamy, MD9; Jennifer Nevas, CRNP10; Caroline H. Rao, MD11; Allen J. Gifford, PA-C11; Kelly A. Asher, PA-C11; Adela Rambi G. Cardones, MD11; Angela F. Richardson, MHS, PA-C11; Carmen Adams Patrick, PA12. Cooperative Studies Program Coordinating Center, MAVERIC, Boston, Massachusetts: Louis Fiore, MD, MPH; Ryan E. Ferguson, ScD, MPH; Soe Soe Thwin, PhD, MS; Robert Lew, PhD; Clara E. Kebabian, MPH; Jennifer Pavao. Cooperative Studies Program Clinical Research Pharmacy Coordinating Center, Albuquerque, New Mexica: Mike Sather PhD; Carol Fye, MS; Robert Ringer, PharmD, BCNP; David Hunt, MS. Dermatopathologists, Providence, Rhode Island: Leslie Robinson-Bostom, MD; Gladys Telang, MD; Caroline Wilkel, MD. Data and Safety Monitoring Board: Harley A. Haynes, MD (chair); Maurice Alan Brookhart, PhD; Eliot N. Mostow, MD, MPH; Thomas Rector, PharmD, PhD. Clinical Centers:1Bay Pines, Florida; 2Hines, Illinois; 3Palo Alto, California; 4Atlanta, Georgia; 5San Diego, California; 6Minneapolis, Minnesota; 7Nashville, Tennessee; 8Denver, Colorado; 9Boston, Massachusetts; 10Philadelphia, Pennsylvania; 11Durham, North Carolina; 12Miami, Florida.
Disclaimer: The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the US Department of Veterans Affairs.
Previous Presentation: This article was presented at the Annual Meeting of the Society for Investigative Dermatology; May 7, 2015; Atlanta, Georgia.